复旦儿科医联体呼吸协作网揭牌,推进儿科分级诊疗

2019-10-12 陈静 罗燕倩 中国新闻网

如今,肺炎仍是五岁以下儿童死亡的三大原因之一,是危害儿童健康的主要疾病。而不同级别医疗机构的医生同质化水平差,使得孩子罹患呼吸系统疾病时,家长第一时间总是寄望三甲儿童专科医院。如何改变这样的状况,成为当下上海医疗界思考的问题。11日,由复旦大学附属儿科医院呼吸科牵头,包括上海市南片区的12家综合医院和29家社区卫生服务中心正式成立了复旦儿科医联体呼吸协作网。复旦大学附属儿科医院呼吸科主任王立波教授

如今,肺炎仍是五岁以下儿童死亡的三大原因之一,是危害儿童健康的主要疾病。而不同级别医疗机构的医生同质化水平差,使得孩子罹患呼吸系统疾病时,家长第一时间总是寄望三甲儿童专科医院。如何改变这样的状况,成为当下上海医疗界思考的问题。

11日,由复旦大学附属儿科医院呼吸科牵头,包括上海市南片区的12家综合医院和29家社区卫生服务中心正式成立了复旦儿科医联体呼吸协作网。

复旦大学附属儿科医院呼吸科主任王立波教授介绍,呼吸系统疾病占儿科门急诊的70%左右。他接受采访时直言,与三甲儿童专科医院相比,二级医院、社区卫生服务中心等医生的水平差距不小。基层医院的医生更擅长急性呼吸道疾病的诊治,而对慢性疾病的治疗并不十分在行。同时,基层医院化存在检查不全,用药水平参差不齐,这导致了治疗效果不尽人意。

王立波认为,提高复旦儿科医联体综合医院及基层医疗机构的儿童呼吸系统疾病的诊治能力刻不容缓,这也是提升区域儿童健康服务能力建设的重要举措。他指出,复旦儿科医联体呼吸协作网的成立,日后将成为推进儿科分级诊疗制度落地的有效措施。

王立波透露,复旦儿科医联体呼吸协作网将带动医联体成员单位规范诊疗,提高同质化服务水平,提升儿科呼吸系统疾病诊治水平,实现儿科资源共享、优势互补、合作共赢。

复旦儿科医联体呼吸协作网将致力建立儿童呼吸道疾病一体化标准化临床体系、建立完善呼吸疾病分级诊疗和双向转诊机制、建立呼吸专科人才培养体系、建立学术交流及科研合作体系。

揭牌仪式后举行的“整合优质儿科资源,构建儿童健康服务网——复旦儿科医联体儿童健康服务案例分享会”上,来自徐汇、闵行、松江、青浦、金山五区的10家综合医院及社区卫生服务中心分享了儿童健康服务案例。医生们围绕着整合儿科医疗资源提供连续性儿童健康服务、为儿童提供同质化健康及医疗服务、持续提升儿科服务质量三个主题开展分享交流,取长补短,互相借鉴。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2019-10-14 saikp
  4. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2019-10-13 深海的鱼

    学习学习,,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2046368, encodeId=cd182046368e7, content=<a href='/topic/show?id=88b4359488a' target=_blank style='color:#2F92EE;'>#协作网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35948, encryptionId=88b4359488a, topicName=协作网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Mon Sep 07 20:50:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335757, encodeId=18d51335e5753, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538575, encodeId=46e015385e548, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Mon Oct 14 14:50:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373835, encodeId=7fad3e38353c, content=学习学习,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sun Oct 13 07:14:05 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373832, encodeId=28213e383268, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sun Oct 13 05:06:15 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373830, encodeId=a11c3e3830da, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Oct 13 01:01:08 CST 2019, time=2019-10-13, status=1, ipAttribution=)]
    2019-10-13 飛歌

    学习了很有用不错

    0

相关资讯

蛋形视听舱、机器人馆员……复旦新医科图书馆未来感十足

图书馆可以是什么样的?复旦大学图书馆医科馆的馆员们,用三年时间给出了自己的答案:这并非仅是看书还书的地方。复旦大学表示,历时三年的原址重建后,该校新落成的图书馆医科馆(以下称“复旦医馆”),将于2017年11月21日向读者开放。11月13日下午,记者提前探访了这座高八层,总建筑面积约18000平方米的新图书馆。和以前最大的不同是,其大部分空间留给了读者而非书籍:一些区域配有专门的投影设备,供学生讨

复旦肿瘤医院季冬梅:病理检查是指导淋巴瘤治疗的“灯塔”

淋巴瘤是淋巴造血系统的一种常见肿瘤,往往可以发生在人体除了头发和指甲以外的任何器官。那生了淋巴瘤应该怎么治疗呢?这个问题还真不容易回答。总体来说,淋巴瘤的治疗应该是以化疗为主的综合治疗,但具体到某一个特定患者的治疗的时候,到底应该采用哪种具体方法或者哪些药物,其决定性因素是这个肿瘤的具体病理类型。因为淋巴瘤是原发淋巴系统的一类恶性肿瘤的总称,它不是一个单独的疾病,还包括非常多的亚型。根据2016年

Molecular Therapy Nucleic Acids:复旦团队研制出诱导型基因编辑ZFN靶向切除近10kb 全长HIV-1前病毒

近日,复旦大学生命科学学院遗传工程国家重点实验室朱焕章课题组设计并构建出只在HIV感染细胞上才能切除HIV-1前病毒的诱导型锌指蛋白核酸酶(ZFN-Tat),避免了ZFN持续表达可能引起的潜在脱靶效应,为该技术在临床上安全、有效地应用奠定了基础。相关研究结果近日发表在国际知名期刊《Molecular Therapy- Nucleic Acids》

EBCC-11∣邵志敏教授团队:年轻乳腺癌患者总生存率与疾病特异生存率列线图的构建与验证

第11届欧洲乳腺癌大会于当地时间3月21日在西班牙巴塞罗那拉开序幕。复旦大学附属肿瘤医院邵志敏团队关于构建年轻乳腺癌患者生存预后风险评估模型的研究入选大会壁报。

直面衰弱与死亡,这群复旦人接力与“癌中之王”搏斗

胰腺外科主任虞先浚从1999年开始专攻胰腺癌,至今已经二十年。年轻时,他曾以“把胰腺肿瘤攻克”为目标。“那个时候决心很大。”虞先浚说,“结果和这个肿瘤搏斗了将近二十年,虽然诊治水平已经取得了很大的进步,但是路还很遥远,我们还在努力中。”2017年12月25日晚七点半,林深的父亲带着身上的三根引流管、呼吸器和镇痛包,从复旦大学附属肿瘤医院胰腺外科(以下简称“胰腺外科”)的手术室里被推了出来。这场

教育部、国家卫健委、上海共建托管复旦上海医学院及附属医院

12月21日,教育部、国家卫生健康委员会、上海市人民政府共建托管复旦大学上海医学院及其直属附属医院签约仪式在京举行。教育部党组书记、部长陈宝生,上海市委副书记、市长应勇,国家卫生健康委员会副主任曾益新出席签约仪式并讲话。仪式上具体说了哪些内容?共建协议都有啥举措?随教育小微一起看现场↓↓↓学校未来办学怎么办?听听陈宝生部长怎么说↓↓↓陈宝生:要充分利用共建托管的综合优势,加快建设一流医学院、打造一